TERT and cancer: In fact, more than 90% of all cancers acquire the capability to replicate indefinitely through the re-activation of telomerase, a ribonucleoprotein complex containing an internal RNA template and the catalytic protein telomerase reverse transcriptase (TERT), with telomere specific reverse transcriptase activity (34).